Biography

• Director of the Atrial Fibrillation Diagnosis and Treatment Center of Shanghai Jiao Tong University, Director of the Atrial Fibrillation Center in Shanghai Chest Hospital, Archiater, Secondary Professor, Doctor of Medicine (M.D.), Doctoral Supervisor, Recipient of Special Allowances endowed by State Council, Shanghai Outstanding Academic Leader, Shanghai Leading Medical Talent, Shanghai Silver Snake Award Winner.

• Former chairman of Shanghai Heart Pacing and Electrophysiology Society, Director of Shanghai Biological Medical Engineering Society, Expert member of Heart Arrhythmia Group of Cardiovascular Branch of Chinese Medical Association, Editorial Board of Chinese Journal of Interventional Cardiology, Circulation~AE, Editorial Committee of PACE Journal, Associate Editor for the topic “Clinical EP and VT ablation” of Europace.

• As an international renowned expert in the field of diagnosis and treatment of atrial fibrillation for cardiovascular diseases , he has completed 50,000 cases of catheter ablation treatment of arrhythmias, including 30,000 case of catheter ablation of atrial fibrillation (AF), ranked at the top of Asia-Pacific Region for 10 consecutive years.

• As the first person in charge, he undertook and obtained National Natural Fund for 24 projects under national ‘863’ plan and significant R&D projects, publishing over 150 papers with a total influence factor of 300 points. Won 8 awards at the provincial and ministerial level, including 2nd prize of National Science and Technology Progress, 2nd Prize of Education Ministry Science and Technology Progress, 1st prize of Shanghai Medical Science and Technology. He has edited more than 10 monographs on 1stEdition, 2ndEdition and 3rdEdition of Atrial Fibrillation Catheter Ablation, with a total of more than 4 million characters.

Publications

1. Yi Yi, Lili Du, Mu Qin, et al. Regulation of Atrial Fibrosis by the Bone. Hypertension. 2019;73(2):379-389.  Corresponding author

2. Song ZL, Wu SH, Zhang DL, Jiang WF, Qin M, Liu X. Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke. Front Cardiovasc Med. 2021 Mar 10;8:630090. Corresponding author

3. Song Z, Xu K, Hu X, Jiang W, Wu S, Qin M, Liu X.A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients.Front Cardiovasc Med. 2020 Nov 5;7:604795. Corresponding author

4. Hu X, Jiang W, Wu S, Xu K, Zhang D, Zhang Y, Liu X, Qin M.Extra-pulmonary vein driver mapping and ablation for persistent atrial fibrillation in obese patients. Europace. 2021 May 21;23(5):701-709. Corresponding author

5. Li kg, Qin m, Jiang wf, et al. Management of catheter ablation in arrhythmia patients during the coronavirus disease 2019 epidemic. ESC Heart Fail. 2020 Sep 17;7(6):4032-4039. Corresponding author

6. Lin R, Wu S, Zhu D, Qin M, Liu X. Osteopontin induces atrial fibrosis by activating Akt/GSK-3β/β-catenin pathway and suppressing autophagy. Life Sci. 2020 Mar 15;245:117328. Corresponding author

7. Qin M, Jiang WF, Wu SH, Xu K, Liu X. Electrogram dispersion-guided driver ablation adjunctive to high-quality pulmonary vein isolation in atrial fibrillation of varying durations. J Cardiovasc Electrophysiol. 2020 Jan;31(1):48-60. Corresponding author

8. Qin M, Zeng C, Liu X.The cardiac autonomic nervous system: A target for modulation of atrial fibrillation. Clin Cardiol. 2019 Jun;42(6):644-652. Corresponding author

9. Lin R, Zeng C, Xu K, Wu S, Qin M, Liu X. Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation. Int J Cardiol. 2019 Mar 1;278:97-103. Corresponding author

10. Qin M, Lin RJ, Wu SH, Liu X. Extra pulmonary vein driver mapping and ablation in paroxysmal atrial fibrillation by electrogram dispersion analysis. J Cardiovasc Electrophysiol. 2019 Feb;30(2):164-170. Corresponding author